My "epidemic of war"
Release time:
2020-07-22
My "War Epidemic "
5# August 10 , three days before I returned to Guizhou Peak after my internship, I was ill.
I felt uncomfortable on the night shift. I thought it would be good to sleep, but it became more and more serious. my temperature soared to 38.6 ℃ ! What a terrible thing this is at this extraordinary time! Although I know very well in my heart that medicine is now so advanced that even if I hit the new coronavirus, it can be cured, but all the news I have experienced and heard about the global "epidemic " over the past few months, it is impossible to say that there is no pressure. Not afraid of your jokes, when I saw the numbers on the thermometer, the first sentence that came to my mind was, "Chen Xiaomin, aged 23 " .
Colleague Zhang Jie also had the same symptoms as me. She cried. She is a mother, a wife and a daughter, so she worries a lot. I understand her mood very well, but am I not the same myself? I think I am strong enough to pretend to be calm and calm, but I am so flustered that I dare not tell my family for fear that they are worried. Looking at the phone calls from colleagues and family members one by one, my heart was empty, as if I had no relatives around me. After sorting out the mood, I finally couldn't help calling home and chatting. Tears poured up and I couldn't stop sobbing. During the internship has been trying to overcome the unaccustomed life, but also suddenly burst out, let me very homesick. From the beginning of the internship, I was looking forward to going home, and finally I was almost there, but there was such a problem. I was so afraid that I couldn't go home.
I Baidu a lot of information, high fever does not subside, diarrhea, dry cough and fever, these are consistent with the new crown symptoms. And our situation has also attracted everyone's attention. For a while, not only Daye Peak was extremely nervous, but it was quickly disinfected. Even the leaders of Guizhou Peak hundreds of kilometers away were alarmed. Colleagues Orchid and Xiaolong returned to the dormitory for isolation. Zhang Jie and I were admitted to the hospital. To be honest, I am not afraid of being infected with the new coronavirus. What puts pressure on me is more physical and mental discomfort. I am afraid of pain, afraid of everyone's resistance to us, afraid of being blamed for bringing the virus to others, afraid of relatives afraid of seeing us ...... Because of all this fear, I can finally truly understand the feelings of the new coronary pneumonia patients. Many things cannot be expressed in words. You have to experience them yourself.
On the first day of admission, I was very tossed. My body temperature dropped and rose, and I was checked by the doctor again. I couldn't sleep all night. Looking at the empty room, I couldn't help feeling scared, so I got up and wiped all the places that the medical alcohol handle in the corridor often touched. Lying on the bed, the quilt is very thick, hot, and dare not kick away, although the clothes have been soaked with sweat, also dare not. I don't want to inconvenience others. Although wearing a mask is very sultry, I have to wear it even if I sleep in my room. When the nurse changed medicine to measure her temperature, I also tried not to touch her and left her some space. The days of hospitalization were really hard, counting the seconds. On the evening of
11 , Zhang Jie's fever completely subsided and her physical condition was normal, while I was still over 38 degrees, and my mood was absolutely terrible. I'm afraid I won't get better, I'm afraid I'll still be in the hospital after she's out of the hospital, and even more afraid, maybe I really got a new crown? Finally, the final test results came out, the nucleic acid test results showed negative, I couldn't help but cry with joy, holding the phone to reply to everyone's messages one by one. Talking to colleagues about "Chen Xiaomin died at 23 " made everyone burst into laughter, and I couldn't help laughing. Yes, I just want to make everyone laugh, relieve the tension these days, and celebrate that everyone can go home together after discharge.
Although it was only a false alarm, I cannot forget that when Master Beijie learned that I had a fever, she immediately called her husband to send me a thermometer. During the hospitalization, the leaders, colleagues and teachers of Daye Peak and Guizhou Peak were worried about our bad food, our unaccustomed life, and gave us food and daily necessities, every day many times to ask our situation ...... these information are too much to reply, I really feel the warmth of home.
's internship in daye peak is a very rare learning opportunity. after this special "war epidemic " , I have deeply imprinted all the stories that happened here in my mind and believe that I will never forget them in my life. Here, I feel the warmth of the spike family. When I needed comfort and help most, it was the spikes that gave me spiritual comfort and moved me much. I'm going to say "Thank you " to all the spikes.
Because of this experience, I also have a special feeling about the new crown epidemic. I sincerely hope that this disaster will end soon, and I believe that as long as we unite as one, we will be able to defeat the new coronavirus and reappear a healthy and beautiful China. Come on, China! (chen xiaomin)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31